查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086245

預填充式注射器市場：2026-2032年全球市場預測（依產品類型、材質、容量、設計、應用、最終用戶及通路分類）

Prefilled Syringes Market by Product Type, Material Type, Volume, Design, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，預填充式注射器市場規模將達到 166.1 億美元，複合年成長率為 9.90%。

主要市場統計數據
基準年 2025 85.7億美元
預計年份：2026年 93.5億美元
預測年份 2032 166.1億美元
複合年成長率 (%) 9.90%

預填充式注射器市場概覽

預填充式注射器市場正從以便利性為導向的包裝類別，轉型為生物製藥、疫苗、抗凝血劑、急救藥物、眼科藥物和慢性病治療藥物的策略性給藥平台。這項需求的促進因素包括：持續向自我給藥和居家照護的轉變、管瓶的上市，以及對「即用型」製劑日益成長的需求。與傳統的西林瓶加注射器的工作流程相比，即用型製劑形式能夠減少配製步驟、降低污染風險並減少劑量差異。

預填充式注射器產業的變革性變化

高價值生技藥品和生物相似藥的興起正在重塑這一市場格局。這些產品需要使用能夠保護敏感分子免受吸附、聚集、矽油相互作用、鎢殘留和玻璃分層影響的容器。這加速了採用先進玻璃系統和由環烯烴聚合物及環烯烴共聚物製成的注射器來治療藥物的需求，這些治療藥物需要降低破損風險、提高尺寸穩定性、減少蛋白質相互作用，並在檢查過程中具有良好的可視性。

人工智慧對預填充式注射器的累積影響

人工智慧 (AI) 正透過機器視覺檢測、異常檢測、預測性維護、數位化批次審核、製程監控和需求預測等方式，開始影響預填充式注射器的價值鏈。當在經過驗證的品質系統中實施時，AI 驅動的視覺檢驗有助於識別外觀缺陷、異物、容量差異、活塞錯位、針頭保護罩缺陷和針帽不匹配等問題。

關於預填充式注射器的關鍵區域見解

亞太地區是預填充式注射器的重點市場。這是因為中國、印度、日本、韓國和澳洲擁有大規模的患者群體、不斷擴展的生物製藥研發管線、對糖尿病治療和免疫接種計劃的巨大需求，以及日益完善的國內灌裝和包裝能力。日本和韓國專注於品質至關重要的注射劑療法、受監管藥品和醫療設備的性能以及卓越的生物製藥生產，而中國和印度則正在擴大生物相似藥和疫苗的生產，以滿足日益成長的即用型和即灌型製劑的需求。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

隨著東協地區製藥業的擴張以及醫療體系改善注射劑的可及性，該地區市場的重要性日益凸顯。儘管監管協調仍存在不平衡，但印尼、泰國、馬來西亞、越南和菲律賓的疫苗接種計劃、糖尿病管理、醫院現代化以及不斷擴大的私人醫療網路支撐了市場需求。海灣合作理事會（GCC）成員國優先推進醫療現代化、本地製造夥伴關係、建立穩健的進口管道以及發展高價值注射劑低溫運輸系統，預填充式注射器在專科醫療和慢性病管理中正發揮著越來越重要的作用。

主要國家預填充式注射器的發展趨勢

在美國，預填充式注射器的普及主要源於人們對更便捷給藥方式的偏好，尤其是在提供適當培訓、清晰標籤和符合人體工學原理的支持下，生物製藥、生物類似藥、疫苗、GLP-1療法、急救藥物以及患者便利性方面都得到了廣泛應用。在加拿大，預充式注射器採用以品質為中心的模式，其需求與慢性病治療、公共醫療保險報銷決策、專科藥房分銷以及獲得受監管生物製藥的途徑密切相關。墨西哥和巴西是拉丁美洲的核心市場，注射藥物、糖尿病護理、免疫接種活動以及區域生產夥伴關係的增加推動了預填充式注射器在這些地區的普及。

為行業領導者提供的實用建議

產業領導者應從研發初期就優先考慮藥物容器的兼容性。這包括萃取和洗脫性能、對矽膠的敏感性、拔出和滑動力性能、容器和密封系統的完整性、活塞和塞子的兼容性、顆粒控制以及滅菌影響。對於生技藥品和高黏度製劑，早期評估玻璃與聚合物圓筒、針頭規格、注射力、殘留量以及自動注射器整合等因素，可以降低後期研發階段的重新設計和監管風險。

調查方法

本執行摘要採用系統的二手研究方法編寫，重點關注藥品生產和注射劑領域的監管指南、藥典標準、公共衛生重點、行業申報、檢驗的生產調查方法以及已證實的市場趨勢。主要參考領域包括 ISO 11040、美國藥典 (USP) 中有關包裝完整性和彈性體組件的章節、FDA 和 EMA 對複合產品的要求、歐盟醫療設備法規考量以及普遍接受的無菌和污染控制規範。

結論

預填充式注射器正成為更安全、更快捷、以病人為中心的注射藥物給藥的核心平台。它們的價值不僅限於包裝，還能影響劑量準確性、用藥流程、依從性、無菌性、減少過量填充以及生物製劑、生技藥品類似藥、疫苗、急救藥物和慢性病治療的生命週期管理。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：預填充式注射器市場：依產品類型分類

  • 傳統預填充式注射器
  • 安全型預填充式注射器

第8章：預填充式注射器市場：依材料類型分類

  • 玻璃
    • 硼矽酸玻璃
    • 鈉鈣玻璃
  • 塑膠
    • 環烯烴聚合物
    • 環烯烴共聚物
    • 聚丙烯

第9章：預填充式注射器市場：依銷售量

  • 少於1毫升
  • 1 ml～5 ml
  • 超過 5 毫升

第10章：預填充式注射器市場：依設計分類

  • 雙腔體
  • 單室

第11章：預填充式注射器市場：依應用領域分類

  • 腫瘤學
    • 化療藥物
    • 免疫療法
  • 自體免疫疾病
    • 類風濕性關節炎
    • 多發性硬化症
    • 發炎性腸道疾病
  • 糖尿病
  • 感染疾病
  • 神經病學

第12章預填充式注射器市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 家庭醫療保健
  • 製藥和生物技術公司
  • 合約研究和製造組織

第13章：預填充式注射器市場：依通路分類

  • 離線
  • 線上

第14章：預填充式注射器市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章：預填充式注射器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章預填充式注射器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Becton, Dickinson and Company
  • Gerresheimer AG
  • SCHOTT Pharma
  • West Pharmaceutical Services, Inc.
  • Stevanato Group SpA
  • Nipro Europe Group Companies
  • Fresenius Kabi AG
  • Catalent, Inc.
  • Baxter International, Inc.
  • Terumo Corporation
  • Samsung Bioepis Co., Ltd. by
  • GlaxoSmithKline plc
  • Ypsomed AG
  • Shandong Weigao Group Medical Polymer Company Limited
  • AptarGroup, Inc.
  • AbbVie Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi SA
  • SHL Medical AG
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-030EE48515C9

The Prefilled Syringes Market is projected to grow by USD 16.61 billion at a CAGR of 9.90% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.57 billion
Estimated Year [2026] USD 9.35 billion
Forecast Year [2032] USD 16.61 billion
CAGR (%) 9.90%

Prefilled Syringes Market Introduction

The prefilled syringes market is moving from a convenience-led packaging category to a strategic drug-delivery platform for biologics, vaccines, anticoagulants, emergency medicines, ophthalmic therapies, and chronic disease treatments. Demand is supported by the continued shift toward self-administration, home-based care, biosimilar launches, and ready-to-administer formats that can reduce preparation steps, contamination risk, and dosing variability compared with vial-and-syringe workflows.

For pharmaceutical manufacturers and healthcare providers, prefilled syringes improve dose accuracy, support sterility assurance, reduce drug overfill requirements, and help standardize administration in clinical, ambulatory, and home-care settings. Adoption is closely linked to ISO 11040 syringe standards, combination-product expectations, container closure integrity testing, and tighter requirements for extractables, leachables, particulate control, endotoxin control, and human factors validation.

Transformative Shifts in the Prefilled Syringes Landscape

The landscape is being reshaped by the rise of high-value biologics and biosimilars, which require primary containers that protect sensitive molecules from adsorption, aggregation, silicone interaction, tungsten residues, and glass delamination. This is accelerating adoption of advanced glass systems as well as cyclic olefin polymer and cyclic olefin copolymer syringes for therapies that require lower breakage risk, high dimensional consistency, low protein interaction, and strong visibility during inspection.

Another major shift is the move from clinic-centered administration to patient-centered delivery. Auto-injector compatibility, passive and active safety needle systems, ergonomic flange design, low-dead-space configurations, and connected adherence features are becoming important differentiators. Manufacturers are also investing in nested, ready-to-fill formats, robotic filling lines, isolator-based aseptic processing, and automated visual inspection to improve contamination control, fill-finish efficiency, and commercial supply reliability.

Cumulative Impact of Artificial Intelligence on Prefilled Syringes

Artificial intelligence is beginning to influence the prefilled syringes value chain through machine vision inspection, anomaly detection, predictive maintenance, digital batch review, process monitoring, and demand planning. AI-enabled visual inspection can help identify cosmetic defects, particulates, fill-volume deviations, plunger placement issues, needle shield defects, and closure inconsistencies when deployed within validated quality systems.

The cumulative impact is operational rather than speculative: faster deviation triage, improved line uptime, better inventory planning for components such as barrels, plungers, stoppers, needles, and tip caps, and more robust cold-chain risk management. However, regulated deployment requires data integrity controls, model validation, audit trails, cybersecurity safeguards, human oversight, and alignment with FDA, EMA, 21 CFR Part 11, EU Annex 11, and applicable GxP expectations.

Key Regional Insights for Prefilled Syringes

Asia-Pacific is a high-priority region for prefilled syringes because China, India, Japan, South Korea, and Australia combine large patient populations, expanding biologics pipelines, diabetes treatment needs, immunization programs, and increasing domestic fill-finish capabilities. Japan and South Korea emphasize quality-intensive injectable therapies, regulated drug-device performance, and biopharmaceutical manufacturing excellence, while China and India are scaling biosimilar and vaccine manufacturing with rising demand for ready-to-administer and ready-to-fill formats.

North America remains a leading innovation and commercialization hub due to FDA-regulated combination products, strong biologics and biosimilar adoption, established specialty pharmacy channels, home-care infrastructure, and advanced contract development and manufacturing capabilities. Europe is shaped by EMA requirements, EU Medical Device Regulation considerations for combination products, sustainability expectations, pharmacovigilance obligations, and mature hospital injectable practices. Latin America is led by Brazil and Mexico, where diabetes care, vaccination programs, public procurement, and private healthcare expansion support adoption. The Middle East, particularly GCC markets, is investing in healthcare localization, specialty medicine access, and cold-chain capacity, while Africa's opportunity is tied to immunization, insulin access, public-sector procurement, donor-supported healthcare programs, and supply-chain resilience.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are becoming more relevant as regional pharmaceutical manufacturing expands and health systems increase access to injectable therapies. Regulatory convergence remains uneven, but demand is supported by vaccination programs, diabetes management, hospital modernization, and growing private healthcare networks in Indonesia, Thailand, Malaysia, Vietnam, and the Philippines. The GCC is prioritizing healthcare modernization, local manufacturing partnerships, resilient import channels, and cold-chain readiness for high-value injectable medicines, making prefilled syringes increasingly relevant for specialty care and chronic disease management.

The European Union is influential because its regulatory framework, environmental priorities, medical device rules, and pharmacovigilance expectations often set global benchmarks for prefilled syringe development and lifecycle management. BRICS countries are important for volume-driven access, biosimilar production, public health procurement, and localization initiatives, while G7 markets lead in premium biologics, device-enabled delivery, human factors engineering, and advanced quality systems. NATO-related demand is more specialized, centered on emergency preparedness, medical readiness, secure supply chains, antidote delivery, vaccine readiness, and standardized injectable formats for defense health systems.

Key Country Insights for Prefilled Syringes

In the United States, prefilled syringe adoption is driven by biologics, biosimilars, vaccines, GLP-1 therapies, emergency medicines, and patient preference for convenient administration when supported by appropriate training, labeling, and human factors evidence. Canada follows a quality-focused model with demand tied to chronic disease treatment, public reimbursement decisions, specialty pharmacy distribution, and regulated biologic access. Mexico and Brazil are central Latin American markets, with adoption supported by expanding injectable drug access, diabetes care, immunization activity, and regional manufacturing partnerships.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from mature hospital systems, biosimilar uptake, specialty medicine use, and rigorous combination-product evaluation. Russia maintains demand across vaccines and chronic therapies despite procurement, localization, and supply-chain complexity. In Asia-Pacific, China and India are scaling biologics, biosimilars, vaccines, and fill-finish capacity; Japan prioritizes high-quality drug-device performance and user-centered delivery; South Korea is a major biopharmaceutical manufacturing base with strong injectable expertise; and Australia supports adoption through advanced healthcare access, regulated specialty medicine channels, and established vaccination infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize drug-container compatibility early in development, including extractables and leachables, silicone sensitivity, break-loose and glide-force performance, container closure integrity, plunger stopper compatibility, particulate control, and sterilization impact. For biologics and high-viscosity formulations, early assessment of glass versus polymer barrels, needle gauge, injection force, hold-up volume, and auto-injector integration can reduce late-stage redesign and regulatory risk.

Manufacturers should strengthen dual sourcing for critical components, qualify suppliers against pharmacopeial and ISO requirements, validate AI-assisted inspection under GxP controls, and invest in flexible fill-finish capacity for small-batch biologics and large-volume commercial programs. Commercial teams should align product design with patient usability, healthcare professional workflow, payer requirements, sustainability expectations, cold-chain realities, and regional regulatory pathways to improve launch readiness and lifecycle value.

Research Methodology

This executive summary is developed using a structured secondary research methodology focused on regulatory guidance, pharmacopeial standards, public health priorities, industry filings, validated manufacturing practices, and verified market signals from pharmaceutical manufacturing and injectable drug delivery. Key reference areas include ISO 11040, USP chapters related to packaging integrity and elastomeric components, FDA and EMA combination-product expectations, EU Medical Device Regulation considerations, and recognized aseptic processing and contamination control practices.

The analysis triangulates demand drivers across therapeutic categories, regional healthcare infrastructure, manufacturing capacity, material selection, regulatory pathways, and supply-chain dynamics. Insights are assessed for consistency across quality requirements, technology adoption, clinical use cases, and commercial evidence to provide an objective view of the prefilled syringes market without relying on unsupported claims, market sizing, market share, or forecasting assumptions.

Conclusion

Prefilled syringes are becoming a core platform for safer, faster, and more patient-centered injectable drug delivery. Their value extends beyond packaging, influencing dose accuracy, medication workflow, adherence, sterility assurance, overfill reduction, and lifecycle management for biologics, biosimilars, vaccines, emergency medicines, and chronic disease therapies.

The strongest strategic position belongs to organizations that combine material science, regulatory discipline, aseptic manufacturing excellence, patient-centric design, resilient sourcing, and digital quality systems. As healthcare systems continue shifting toward home administration, specialty medicine access, and efficient injectable care, prefilled syringes will remain a critical enabler of modern pharmaceutical delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Prefilled Syringes Market, by Product Type

  • 7.1. Conventional Prefilled Syringes
  • 7.2. Safety Prefilled Syringes

8. Prefilled Syringes Market, by Material Type

  • 8.1. Glass
    • 8.1.1. Borosilicate Glass
    • 8.1.2. Soda Lime Glass
  • 8.2. Plastic
    • 8.2.1. Cyclic Olefin Polymer
    • 8.2.2. Cyclic Olefin Copolymer
    • 8.2.3. Polypropylene

9. Prefilled Syringes Market, by Volume

  • 9.1. Less Than 1 ml
  • 9.2. 1 ml To 5 ml
  • 9.3. More Than 5 ml

10. Prefilled Syringes Market, by Design

  • 10.1. Dual-Chamber
  • 10.2. Single-Chamber

11. Prefilled Syringes Market, by Application

  • 11.1. Oncology
    • 11.1.1. Chemotherapy Drugs
    • 11.1.2. Immunotherapy
  • 11.2. Autoimmune Diseases
    • 11.2.1. Rheumatoid Arthritis
    • 11.2.2. Multiple Sclerosis
    • 11.2.3. Inflammatory Bowel Disease
  • 11.3. Diabetes
  • 11.4. Infectious Diseases
  • 11.5. Neurology

12. Prefilled Syringes Market, by End User

  • 12.1. Hospitals
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Home Healthcare
  • 12.4. Pharmaceutical & Biotech Companies
  • 12.5. Contract Research & Manufacturing Organizations

13. Prefilled Syringes Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Prefilled Syringes Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Prefilled Syringes Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Prefilled Syringes Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Becton, Dickinson and Company
  • 18.2. Gerresheimer AG
  • 18.3. SCHOTT Pharma
  • 18.4. West Pharmaceutical Services, Inc.
  • 18.5. Stevanato Group S.p.A.
  • 18.6. Nipro Europe Group Companies
  • 18.7. Fresenius Kabi AG
  • 18.8. Catalent, Inc.
  • 18.9. Baxter International, Inc.
  • 18.10. Terumo Corporation
  • 18.11. Samsung Bioepis Co., Ltd. by
  • 18.12. GlaxoSmithKline plc
  • 18.13. Ypsomed AG
  • 18.14. Shandong Weigao Group Medical Polymer Company Limited
  • 18.15. AptarGroup, Inc.
  • 18.16. AbbVie Inc.
  • 18.17. Boehringer Ingelheim Pharmaceuticals, Inc
  • 18.18. Eli Lilly and Company
  • 18.19. F. Hoffmann-La Roche Ltd.
  • 18.20. Janssen Pharmaceuticals, Inc.
  • 18.21. Mylan N.V.
  • 18.22. Novartis AG
  • 18.23. Pfizer, Inc.
  • 18.24. Sanofi S.A.
  • 18.25. SHL Medical AG
  • 18.26. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PREFILLED SYRINGES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PREFILLED SYRINGES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PREFILLED SYRINGES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PREFILLED SYRINGES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SAFETY PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SAFETY PREFILLED SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SAFETY PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GLASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GLASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BOROSILICATE GLASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BOROSILICATE GLASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BOROSILICATE GLASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SODA LIME GLASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SODA LIME GLASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SODA LIME GLASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLASTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PLASTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLASTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CYCLIC OLEFIN POLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CYCLIC OLEFIN POLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CYCLIC OLEFIN POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CYCLIC OLEFIN COPOLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CYCLIC OLEFIN COPOLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CYCLIC OLEFIN COPOLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYPROPYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYPROPYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYPROPYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LESS THAN 1 ML MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LESS THAN 1 ML MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LESS THAN 1 ML MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL 1 ML TO 5 ML MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 1 ML TO 5 ML MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 1 ML TO 5 ML MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MORE THAN 5 ML MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MORE THAN 5 ML MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MORE THAN 5 ML MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DUAL-CHAMBER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DUAL-CHAMBER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DUAL-CHAMBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE-CHAMBER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE-CHAMBER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE-CHAMBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CHEMOTHERAPY DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CHEMOTHERAPY DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CHEMOTHERAPY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RHEUMATOID ARTHRITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RHEUMATOID ARTHRITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RHEUMATOID ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFLAMMATORY BOWEL DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFLAMMATORY BOWEL DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INFLAMMATORY BOWEL DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. G7 PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 246. NATO PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. NATO PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CANADA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CANADA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 265. CANADA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 266. CANADA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 267. CANADA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 268. CANADA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. MEXICO PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. MEXICO PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. MEXICO PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. MEXICO PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 277. MEXICO PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. BRAZIL PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 289. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 290. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 313. GERMANY PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 314. GERMANY PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 315. GERMANY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 316. GERMANY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. GERMANY PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. GERMANY PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 319. GERMANY PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. GERMANY PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 325. FRANCE PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 326. FRANCE PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 327. FRANCE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 328. FRANCE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 330. FRANCE PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 331. FRANCE PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. FRANCE PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 333. RUSSIA PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 337. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 338. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 339. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 340. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 342. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 343. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 345. ITALY PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. ITALY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. ITALY PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. ITALY PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 349. ITALY PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 350. ITALY PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 351. ITALY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 352. ITALY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 353. ITALY PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 354. ITALY PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 355. ITALY PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 356. ITALY PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 357. SPAIN PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 358. SPAIN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 359. SPAIN PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 360. SPAIN PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 361. SPAIN PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 362. SPAIN PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 363. SPAIN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 364. SPAIN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 365. SPAIN PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 366. SPAIN PREFILLED SYRINGES MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
  • TABLE 367. SPAIN PREFILLED SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 368. SPAIN PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 369. CHINA PREFILLED SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 370. CHINA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 371. CHINA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 372. CHINA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 373. CHINA PREFILLED SYRINGES MARKET SIZE, BY PLA